Results
1 -
10 of
17Bagal Sharan K., Brown Alan D., Cox Peter J., Omoto Kiyoyuki, Owen Robert M., Pryde David C., Sidders Benjamin, Skerratt Sarah E., Stevens Edward B., Storer R. Ian, Swain Nigel A..
Ion Channels as Therapeutic Targets: A Drug Discovery Perspective, Journal of Medicinal Chemistry, 2013 A randomized, double-blind, placebo-controlled crossover study of ??4??2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder, Psychopharmacology Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers, Psychopharmacology Targeting the Nicotinic Cholinergic System to Treat Attention-Deficit/Hyperactivity Disorder: Rationale and Progress to Date, CNS Drugs Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy, CNS Drugs Investigational drugs for the treatment of AD: what can we learn from negative trials?, Alzheimer's Research & Therapy Ispronicline, Journal of Molecular Neuroscience Cognitive enhancement in man with ispronicline, a nicotinic partial agonist, Journal of Molecular Neuroscience Nicotinic acetylcholine receptor ??4??2, Science-Business eXchange